Cargando…

Association Between Serological Markers and Crohn’s Disease Activity

BACKGROUND: The aim was to study the association between six serological markers and Crohn’s disease (CD) activity at an inflammatory bowel disease (IBD) referral center. METHODS: We designed a retrospective cohort study using adults (> 18 years) with CD followed for at least 1 year at University...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Zunirah, Lysek, Michael, Zhang, Nan, Malik, Talha A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968925/ https://www.ncbi.nlm.nih.gov/pubmed/32010416 http://dx.doi.org/10.14740/jocmr4016

Ejemplares similares

Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn’s Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center
por: Ahmed, Zunirah, et al.
Publicado: (2019)

Predictors of Outcome of Rectovaginal Fistula Surgery in Women With Crohn’s Disease
por: Manne, Ashish, et al.
Publicado: (2016)

Obesity is Associated With Poor Surgical Outcome in Crohn’s Disease
por: Malik, Talha A., et al.
Publicado: (2013)

Non-invasive Serological Monitoring for Crohn’s Disease Postoperative Recurrence
por: Hamilton, Amy L, et al.
Publicado: (2022)

Body Mass Index Is Associated With Mucosal Disease in Crohn’s: Results of a Case-Control Study
por: Malik, Talha A., et al.
Publicado: (2014)

ELISA Serology for Antibodies Against Chlamydia trachomatis in Crohn’s Disease
por: Van Kruiningen, Herbert J., et al.
Publicado: (2017)

Histoplasmosis With Diffuse Granulomatous Peritonitis in Crohn's Disease: A Mimic of Peritoneal Carcinomatosis
por: Ahmed, Zunirah, et al.
Publicado: (2022)

Obesity and Outcome of Crohn’s Associated Perianal Fistula Surgery: A Case-Control Study
por: Manne, Ashish, et al.
Publicado: (2015)

The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease
por: Yorulmaz, Elif, et al.
Publicado: (2022)

Posterior Reversible Encephalopathy Syndrome (PRES) and Takotsubo: A Heart and Brain Affair!
por: Perwez, Talha, et al.
Publicado: (2021)

Significance of granulomas in the outcomes of Crohn’s disease patients
por: Saade, Marie Christelle, et al.
Publicado: (2022)

Clinical Markers of Crohn’s Disease Severity and Their Association With Opiate Use
por: Cheung, Mary, et al.
Publicado: (2015)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Newly Diagnosed Crohn’s Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts
por: Goren, Idan, et al.
Publicado: (2022)

Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn’s Disease Patients
por: Walker, Caroline, et al.
Publicado: (2018)

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

Monitoring Crohn’s disease activity: endoscopy, fecal markers and computed tomography enterography
por: Lopes, Susana, et al.
Publicado: (2018)

Budesonide Use and Hospitalization Rate in Crohn’s Disease: Results From a Cohort at a Tertiary Care IBD Referral Center
por: Orr, Jordan, et al.
Publicado: (2016)

Serological markers of inflammatory bowel disease
por: Kuna, Andrea Tešija
Publicado: (2013)

Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
por: Słowińska-Solnica, Krystyna, et al.
Publicado: (2021)

Serum Omentin-1 as a Disease Activity Marker for Crohn's Disease
por: Lu, Yan, et al.
Publicado: (2014)

Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case–control study
por: Yao, Fang, et al.
Publicado: (2018)

Can Red Cell Distribution Width Be Used as a Marker of Crohn's Disease Activity?
por: Oliveira, Ana Maria, et al.
Publicado: (2015)

Impact of vitamin D on the hospitalization rate of Crohn's disease patients seen at a tertiary care center
por: Venkata, Krishna V R, et al.
Publicado: (2017)

Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn’s Disease according to the Location of Disease
por: Yang, Dong-Hoon, et al.
Publicado: (2015)

Deciphering salivary microbiome signature in Crohn’s disease patients with different factors contributing to dysbiosis
por: Elzayat, Hala, et al.
Publicado: (2023)

Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
por: Shome, Mahasish, et al.
Publicado: (2022)

RDW as a Surrogate Marker for Active Crohn's Disease: Potential Utility
por: Cravo, Marilia
Publicado: (2016)

Mean platelet volume: a controversial marker of disease activity in Crohn’s disease
por: Liu, Song, et al.
Publicado: (2012)

Rates of hospitalization among African American and Caucasian American patients with Crohn's disease seen at a tertiary care center
por: Walker, Caroline H, et al.
Publicado: (2017)

Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease
por: Zhang, Shulan, et al.
Publicado: (2015)

Associations between Pharmacotherapy for Cardiovascular Diseases and Periodontitis
por: Pająk-Łysek, Ewa, et al.
Publicado: (2021)

Association between Promotor hypomethylation of TFF1 and Crohn’s Disease
por: Hemmati, Sara, et al.
Publicado: (2022)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Telomere Dysfunction–Related Serological Markers Are Associated With Type 2 Diabetes
por: Xiao, Feng, et al.
Publicado: (2011)

Serological markers associated with neuromyelitis optica spectrum disorders in South India
por: Pandit, Lekha, et al.
Publicado: (2016)

Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
por: Ko, Kyoung Ho, et al.
Publicado: (2019)

Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn’s disease: a multicenter cohort study
por: Tang, Nana, et al.
Publicado: (2022)

Plasma-Free Amino Acid Profiles in Crohn’s Disease: Relationship With the Crohn Disease Activity Index
por: Chiba, Toshimi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2eiceptdlp0j3arh6m0p0hmg8q